Dar Al-Shifa Pharmaceuticals Company

PLSE:PHARMACARE Stock Report

Market Cap: US$30.2m

Dar Al-Shifa Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bassim Subhi Farah Nasr

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership45.0%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Bassim Subhi Farah Nasr

no data

Tenure

Mr. Bassim Subhi Farah Khoury Nasr serves as Executive Chairman, Chief Executive Officer and General Manager at Dar Al-Shifa Pharmaceuticals Company (formerly known as Dar Al-Shifa'a for the Manufacturing...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.